Skip to main content

MUTYH-Associated Polyposis

  • Chapter
  • First Online:
Intestinal Polyposis Syndromes

Abstract

MUTYH-associated polyposis (MAP) is an autosomal recessive predisposition to colorectal cancer (CRC) and intestinal polyposis, representing less than 1 % of CRC cases. This condition is characterized by the development of between 10 and 100 colorectal polyps and presents diagnostic challenges due to its phenotypic overlap with other hereditary CRC syndromes, including Lynch syndrome and attenuated familial adenomatous polyposis. This chapter provides a detailed description of MAP, including its clinical characteristics and molecular genetics, as well as implications for affected patients and families including inheritance, genetic testing, surveillance, and preventive recommendations. A proposed algorithm for MUTYH genetic testing is also provided for this important, but rare, hereditary predisposition to CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet. 2002;30(2):227–32.

    Article  CAS  PubMed  Google Scholar 

  2. Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009;136(4):1251–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Nielsen M, Joerink-van de Beld MC, Jones N, Vogt S, Tops CM, Vasen HF, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology. 2009;136(2):471–6.

    Article  CAS  PubMed  Google Scholar 

  4. Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119(4):807–14.

    Article  CAS  PubMed  Google Scholar 

  5. Landon M, Ceulemans S, Saraiya DS, Strike B, Arnell C, Burbidge LA, et al. Analysis of current testing practices for biallelic MUTYH mutations in MUTYH-associated polyposis. Clin Genet. 2015;87(4):368–72.

    Article  CAS  PubMed  Google Scholar 

  6. Guarinos C, Sanchez-Fortun C, Rodriguez-Soler M, Alenda C, Paya A, Jover R. Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J Gastroenterol. 2012;18(20):2452–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Guarinos C, Juarez M, Egoavil C, Rodriguez-Soler M, Perez-Carbonell L, Salas R, et al. Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res. 2014;20(5):1158–68.

    Article  CAS  PubMed  Google Scholar 

  8. Boparai KS, Dekker E, Van Eeden S, Polak MM, Bartelsman JF, Mathus-Vliegen EM, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology. 2008;135(6):2014–8. Epub 2008/11/18.

    Article  CAS  PubMed  Google Scholar 

  9. Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85 e1-10.

    Google Scholar 

  10. Guillen-Ponce C, Castillejo A, Barbera VM, Pascual-Ramirez JC, Andrada E, Castillejo MI, et al. Biallelic MYH germline mutations as cause of Muir-Torre syndrome. Fam Cancer. 2010;9(2):151–4. Epub 2009/12/10.

    Article  PubMed  Google Scholar 

  11. Morak M, Heidenreich B, Keller G, Hampel H, Laner A, de la Chapelle A, et al. Biallelic MUTYH mutations can mimic Lynch syndrome. Eur J Hum Genet. 2014;22(11):1334–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. David SS, O’Shea VL, Kundu S. Base-excision repair of oxidative DNA damage. Nature. 2007;447(7147):941–50. Epub 2007/06/22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lipton L, Tomlinson I. The genetics of FAP and FAP-like syndromes. Fam Cancer. 2006;5(3):221–6. Epub 2006/09/26.

    Article  CAS  PubMed  Google Scholar 

  14. Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A. Working Group of the American College of Medical G, et al. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med. 2014;16(1):101–16.

    Article  CAS  PubMed  Google Scholar 

  15. Nielsen M, Morreau H, Vasen HF, Hes FJ. MUTYH-associated polyposis (MAP). Crit Rev Oncol Hematol. 2011;79(1):1–16.

    Article  PubMed  Google Scholar 

  16. Rouleau E, Zattara H, Lefol C, Noguchi T, Briaux A, Buecher B, et al. First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome. Clin Genet. 2011;80(3):301–3.

    Article  CAS  PubMed  Google Scholar 

  17. Borras E, Taggart MW, Lynch PM, Vilar E. Establishing a diagnostic road map for MUTYH-associated polyposis. Clin Cancer Res. 2014;20(5):1061–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bisgaard ML, Fenger K, Bulow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat. 1994;3(2):121–5.

    Article  CAS  PubMed  Google Scholar 

  19. Castillejo A, Vargas G, Castillejo MI, Navarro M, Barbera VM, Gonzalez S, et al. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. Eur J Cancer. 2014;50(13):2241–50.

    Article  CAS  PubMed  Google Scholar 

  20. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Genetic/familial high-risk assessment: Colorectal. National Comprehensive Cancer Network. 2014.

    Google Scholar 

  21. Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila). 2011;4(5):655–65. Epub 2011/05/06.

    Article  CAS  Google Scholar 

  22. Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med. 2002;346(14):1054–9. Epub 2002/04/05.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342(26):1946–52. Epub 2000/06/30.

    Article  CAS  PubMed  Google Scholar 

  24. Lynch PM, Ayers GD, Hawk E, Richmond E, Eagle C, Woloj M, et al. The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol. 2010;105(6):1437–43. Epub 2010/03/18.

    Article  CAS  PubMed  Google Scholar 

  25. Sturgeon D, Herline AJ, Wise PE. Do NSAIDs suppress polyps in MUTYH-associated polyposis? A case report. Hered Cancer Clin Pr. 2011;9(Suppl 1):36.

    Google Scholar 

  26. Frattini M, Carnevali I, Signoroni S, Balestra D, Moiraghi ML, Radice P, et al. Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations. Cancer Epidemiol Biomarkers Prev. 2005;14(8):2049–52. Epub 2005/08/17.

    Article  CAS  PubMed  Google Scholar 

  27. Jones N, Vogt S, Nielsen M, Christian D, Wark PA, Eccles D, et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology. 2009;137(2):489–94, 94 e1; quiz 725–6.

    Google Scholar 

  28. Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014;146(5):1208–11 e1–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo Vilar M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mork, M.E., Vilar, E. (2016). MUTYH-Associated Polyposis. In: Boardman, L. (eds) Intestinal Polyposis Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-28103-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28103-2_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28101-8

  • Online ISBN: 978-3-319-28103-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics